Iowa Diabetes

Iowa Diabetes is a specialized healthcare and clinical research organization based in Des Moines, Iowa, focused on the treatment and study of metabolic disorders. The company operates as a high-volume clinical trial site, partnering with global pharmaceutical leaders to execute Phase 1 through Phase 4 studies for innovative diabetes and obesity therapies. Beyond research, Iowa Diabetes provides comprehensive endocrinology care, patient education, and community outreach programs to improve long-term health outcomes. Their expertise spans a wide range of modalities, including novel biologics, small molecules, and medical devices such as continuous glucose monitors. By bridging the gap between clinical practice and drug development, the organization offers patients early access to cutting-edge treatments while advancing the standard of care in endocrinology.